Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F5ZVE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency issued a $49.4K firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on April 23, 2025, for the supply of Entyvio 300 mg vials, with completion scheduled for May 14, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order without a set-aside designation. The delivery order is issued under the company's existing indefinite delivery contract (IDC) with DLA under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities nationwide.
Entyvio is a biologic medication used to treat inflammatory bowel conditions, representing the type of specialty pharmaceutical product that DMS Pharmaceutical Group routinely distributes through its federal contract portfolio. As a long-established pharmaceutical wholesaler registered in SAM.gov since 2001, the company has demonstrated consistent capability in supplying branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. This delivery order aligns with DMS Pharmaceutical Group's core business focus and reinforces its position as a critical supplier within the federal pharmaceutical supply chain serving military medical facilities.
Quick answers
Who was awarded contract SPE2DX25F5ZVE?
SPE2DX25F5ZVE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on April 23, 2025.
How much is contract SPE2DX25F5ZVE worth?
The government has obligated $49,449 on SPE2DX25F5ZVE.
Is contract SPE2DX25F5ZVE an order under another contract?
Yes. SPE2DX25F5ZVE is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZVE competed?
The extent of competition for SPE2DX25F5ZVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award